InvestorsHub Logo
Followers 74
Posts 3281
Boards Moderated 0
Alias Born 03/16/2014

Re: Maverick0408 post# 360350

Monday, 03/08/2021 11:23:24 AM

Monday, March 08, 2021 11:23:24 AM

Post# of 703716
Are you sure ...?

CytoDyn Plunges After Covid Phase 3 Trial Data Disappoints
By Esha Dey
(Bloomberg) -- CytoDyn shares dropped over 22% in premarket trading after the company said data from its CD12 clinical trial showed the primary endpoint among all patients in the modified intent-to-treat (mITT) population was not statistically significant.

Headline's like that gets its sold , doesn't need bashers ...
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News